developed novel TPGS‐MA‐CH solid lipid nanoparticles that enhanced drug targeting and bioavailability to tumor tissues by significantly down‐regulating EGFR and Akt phosphorylation and EGFR expression in A549 cells. Here, AKT1 is linked to neoplasm.